Virginia Tech’s COVID-19 analysis lab reached a milestone in March, breaking more than 100,000 samples analyzed since the lab opened less than a year ago.
“It was an emotional moment to see the 100,000th sample arrive,” said Carla Finkielstein, director of the Virginia Tech Molecular Diagnostics Laboratory at the Fralin Biomedical Research Institute at Virginia Tech Carilion School of Medicine (VTC).
“We’ve come so far since we first started,” Finkielstein said. “This achievement is beyond our wildest dreams, but we really can’t spend time reflecting on it. For now, we are not really conscious of what we’ve achieved. We just keep moving samples. We are on autopilot, reporting the results of our sample testing as fast as we can to public health officials to help contain the virus.”
As of Friday, April 2, Virginia Tech had processed 113,031 samples. The lab opened on April 20, 2020, and received permission from the Food and Drug Administration to carry out testing while its Emergency Use Authorization was under consideration in order to help expand public health lab testing capacity in Southwest Virginia.
“We will have a much larger celebration once the pandemic is over,” said Finkielstein, an associate professor with the Fralin Biomedical Research Institute at VTC and the College of Science’s Department of Biological Sciences. “The team members are honored for the opportunity to serve their community and look forward to a not-so-distant future when there are zero samples to process.”
“Dr. Finkielstein took a bold and innovative series of steps early in the pandemic to position the commonwealth to rapidly stand up and sustain a state-of-the-art COVID-19 testing operation for the citizens of the southwest region of our state, including the Virginia Tech community at a time of great need,” said Michael Friedlander, Virginia Tech’s vice president for health sciences and technology and executive director of the Fralin Biomedical Research Institute.
Finkielstein shifted her attention from her laboratory’s cancer research and enlisted “a small army of volunteers” at the Fralin Biomedical Research Institute to work day and night with her to develop a reliable qRT-PCR-based assay that could be validated, could be submitted to the FDA for consideration for Emergency Use Authorization, and could avoid the flawed tests kits and potential reagent supply chain challenges on the horizon for the nation.
On Nov. 10, 2020, state officials announced Virginia Tech’s COVID-19 lab was selected as one of three exclusive OneLab Network Tier 2 laboratories to expand virus testing capacity across Virginia. By being included in the OneLab Network, Virginia Tech can be called upon to receive samples from any health district in the state, depending on the greatest need.
Since opening, the Molecular Diagnostics Lab has analyzed thousands of Virginia Tech Virginia Tech students and employees who were tested for the COVID-19 virus through the university’s testing centers. That’s in addition to testing done for regional health districts since April 20, 2020.
